GovChime
Notice ID: b282dc9e8acc4a928ab3a5823a5dd0f3Award NoticeAwardedArchived

SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

Awarded on September 30, 2026. Full description on SAM.gov.

Awarded tounder HT001426FE141 (source: SAM.gov award notice)• $480.1K

Overview

Posted
October 8, 2026
Notice type
Award Notice
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY
Place of performance
Bethesda, Maryland, 20889
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Sep 30, 2026
Award amount (SAM.gov award notice)
$480.1K

Identifiers

Solicitation number
12481254
Notice ID
b282dc9e8acc4a928ab3a5823a5dd0f3
Award number (PIID)
HT001426FE141

Description

Clinical Utility: It is used for targeted radioligand therapy for specific types of prostate cancer within the Nuclear Medicine Division of the Department of Radiology at WRNMMC. Novartis Pharmaceuticals Corporation is the sole source for Pluvicto. Therefore, the recommended course of action is to award a contract directly to Novartis. This approach is deemed to be in the government's best interest to ensure the seamless delivery of these critical supplies and maintain continuity of patient care at WRNMMC. The acquisition will be treated as a sole-source procurement.

Full description on SAM.gov

Award Overview

Award Number

HT001426FE141

Award Amount (SAM.gov award notice)

$480.1K

Award Date

Sep 30, 2026

Awardee

Awardee UEI

NG61ZA8TADW3

Awardee CAGE Code

04520

Awardee Address

East Hanover, NJ 07936, UNITED STATES

Original Solicitation

Notice ID: b282dc9e8acc4a928ab3a5823a5dd0f3

Posted Date: Oct 8, 2026

Original Response Deadline: Not specified

Contract Details

Contract data not yet available

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

Contacts

Documents

No documents available.

Lifecycle

  1. 3
    Version 3Award NoticeArchivedCurrent

    SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

    Notice b282dc9e8acc4a928ab3a5823a5dd0f3 on SAM.gov

Similar Opportunities

No similar opportunities found

No similar opportunities match this opportunity's profile.

Additional Details

Solicitation Number

12481254

Archive Date

Oct 15, 2026

Office Address

FALLS CHURCH, VA, 22042